Normal view MARC view ISBD view

External Validation of the COVID-NoLab and COVID-SimpleLab Prognostic Tools. - 2022

Available online through MWHC library: May 2003 - present

Our objective was to externally validate 2 simple risk scores for mortality among a mostly inpatient population with COVID-19 in Canada (588 patients for COVID-NoLab and 479 patients for COVID-SimpleLab). The mortality rates in the low-, moderate-, and high-risk groups for COVID-NoLab were 1.1%, 9.6%, and 21.2%, respectively. The mortality rates for COVID-SimpleLab were 0.0%, 9.8%, and 20.0%, respectively. These values were similar to those in the original derivation cohort. The 2 simple risk scores, now successfully externally validated, offer clinicians a reliable way to quickly identify low-risk inpatients who could potentially be managed as outpatients in the event of a bed shortage. Both are available online (https://ebell-projects.shinyapps.io/covid_nolab/ and https://ebell-projects.shinyapps.io/COVID-SimpleLab/). Copyright © 2022 Annals of Family Medicine, Inc.


English

ISSN: 1544-1709

Standard No.: 10.1370/afm.2872 [doi] 20/6/548 [pii]

Subjects--Topical Terms:
*COVID-19
Canada/ep [Epidemiology]
Humans
Inpatients
Outpatients
Prognosis

Subjects--Geographic Terms:
MedStar Washington Hospital Center

Index Terms--Occupation:
Emergency Medicine

Index Terms--Function:
Journal Article